Hypertension (high blood pressure) Board decisions

The Board remands the claims for service connection for a psychiatric disorder, hypertension, and atrial fibrillation to correct a duty to assist error.

The Veteran withdrew his appeals for service connection for bilateral hearing loss, tinnitus, migraine headaches, hypertension, and sleep apnea.

The Board remands the claims for service connection for various conditions due to an error in verifying the Veteran's active service and obtaining his complete service personnel records and treatment records.

The Board denied an initial compensable rating for hypertension and remanded the claims for service connection for a respiratory condition and congestive heart failure due to deficiencies in the duty to assist.

The Board denied the Veteran's claims for service connection for colon cancer and hypertension, as there was no evidence of a current disability or that these conditions were related to her military service.

The Board denied service connection for tinnitus and remanded the claims for hypertension and GERD due to inadequate medical opinions.

The Board dismissed the veteran's appeals for an increased rating and service connection due to erroneous docketing of the same issues.

The Board denied service connection for hearing loss, hypertension, migraines, and obstructive sleep apnea (OSA) as the evidence did not support a finding that these conditions were related to the appellant's military service. The claims for service connection for right foot disability, left foot disability, cervical strain, lumbar strain, left upper extremity (LUE) radiculopathy, right upper extremity (RUE) radiculopathy, left lower extremity (LLE) radiculopathy, right lower extremity (RLE) radiculopathy, left knee disability, and right ankle disability were remanded for further development.

The Board denied an effective date prior to June 3, 2019 for the grant of service connection for hypertension.

The appeal for service connection for multiple conditions was dismissed due to the untimely filing of the Board Appeal request.

The Board granted service connection for heart attack (myocardial infarction) status post triple coronary bypass, degenerative disc disease of the thoracolumbar spine, and an initial 10 percent rating for hypertension.

The Board granted service connection for hypertension, finding that the evidence supports a nexus between the Veteran's current condition and his active duty service.

The Board dismissed the motions for revision of clear and unmistakable error in various rating decisions, including those related to service connection and ratings for multiple conditions. The claims for service connection were remanded.

The Board denied an initial disability rating in excess of 50 percent for PTSD and an initial disability rating in excess of 10 percent for high blood pressure, both for purposes of accrued benefits.

The Board remands the claims for service connection for hypertension, peptic ulcers, prostate cancer, and valvular heart disease due to inadequate VA examinations that did not consider the Veteran's exposure to ionizing radiation.

The Board granted service connection for various conditions, including neck disability manifested by pain and diabetes mellitus type II, secondary to the Veteran's service-connected bilateral knee degenerative arthritis. The other conditions were also granted as they are caused by the now-service-connected diabetes mellitus type II.

The Board denied a compensable disability rating for the Veteran's service-connected hypertension as the evidence did not show that the condition met the criteria for a 10% rating or higher.

The Board remands the Veteran's claim for an increased evaluation for diabetes mellitus type II, to include separate compensable ratings for diabetic retinopathy, hypertension, hypertensive retinopathy, atrial fibrillation, and stroke residuals.

The Board remands the claims for service connection for diabetes mellitus, type II and hypertension to correct duty to assist errors that occurred prior to the rating decision on appeal.

The Board granted an effective date of March 2, 2023 for heart disease and September 28, 2023 for chronic renal failure, while denying earlier effective dates for PTSD, migraines, diabetes mellitus type II, hypertension, and bilateral hearing loss. The Board also granted a 70 percent evaluation for PTSD.